A major battle is shaping up over some $123 million in attorney fees in the massive Bank of America overdraft class action. An Argentinian law firm is asking a federal judge to allow it to intervene in the case, while plaintiffs attorneys want their bid for fees to be decided in Florida state court.

In the massive litigation over alleged side effects from the diabetes drug Avandia, a Pennsylvania federal judge has issued a pair of opinions that reject efforts by the drug’s maker, GlaxoSmithKline, to significantly limit the scope of the case.

The wheels of justice are turning slowly in the massive IPO securities litigation spawned by the Internet bubble of the late ’90s, with appeals by class members and lawyers alike stalling any distribution of the $586 million settlement, which includes $170 million in legal fees.

This week’s Supreme Court decision in the massive discrimination class action against Wal-Mart has left in-house lawyers with a number of questions — including whether delegating responsibility to local managers might help protect companies from class actions.

In the massive litigation over side effects from the diabetes drug Avandia, a federal judge has dismissed all claims brought by insurers acting as “Medicare Advantage Organizations” that demanded reimbursements from the settlements paid out by GlaxoSmithKline.